A pre-trial evaluation of blinding for a Chinese herbal medicine trial
Background: Blinding is considered an important methodological characteristic in clinical trials to minimise bias and maximise the validity of a trial. Unlike pharmaceutical substances, most herbal medicines have distinctive sensory specifications, including odour and taste, which can be quite chall...
Main Authors: | Shohreh Razavy, John Lee, Christopher Zaslawski |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Contemporary Clinical Trials Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451865420301162 |
Similar Items
-
Efficacy of Chinese herbal medicine in functional dyspepsia: A meta-analysis of randomized, double-blind, placebo-controlled trials
by: Yu Guo, et al.
Published: (2016-07-01) -
The Efficacy and Safety of a Fixed Combination of Chinese Herbal Medicine in Chronic Urticaria: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
by: Sien-Hung Yang, et al.
Published: (2018-12-01) -
Placebo design in WHO-registered trials of Chinese herbal medicine need improvements
by: Xuan Zhang, et al.
Published: (2019-11-01) -
Herbal Medicine Formulas for Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Double-Blind Placebo-Controlled Clinical Trials
by: Chun-Shuo Shan, et al.
Published: (2018-11-01) -
Chinese herbal formula Xuefu Zhuyu for primary dysmenorrhea patients (CheruPDYS): a study protocol for a randomized placebo-controlled trial
by: Geng Li, et al.
Published: (2021-01-01)